Sequence information
Variant position: 335 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 620 The length of the canonical sequence.
Location on the sequence:
SIPLLINYHQHNGGGLVTRL
R YPVCFGRQKAPVTAGLRYGK
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human SIPLLINYHQHNGGGLVTRLR YPVCFGRQKAPVTAGLRYGK
Mouse SIPLLIQYHQYNGGGLVTRLR YPVCSWRQKAPVTAGLRYGK
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 620
Tyrosine-protein kinase ITK/TSK
Domain
239 – 338
SH2
Literature citations
Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.
Huck K.; Feyen O.; Niehues T.; Rueschendorf F.; Huebner N.; Laws H.-J.; Telieps T.; Knapp S.; Wacker H.-H.; Meindl A.; Jumaa H.; Borkhardt A.;
J. Clin. Invest. 119:1350-1358(2009)
Cited for: VARIANT LPFS1 TRP-335; CHARACTERIZATION OF VARIANT LPSA1 TRP-335;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.